Results 171 to 180 of about 93,786 (305)

Novel and emerging antimicrobial strategies in the management of oral infections

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Antibiotics marked a pivotal turning point in human civilization, enhancing social interactions and extending human life expectancy. In addition to their success in treating systemic infectious diseases, they have significantly improved periodontal treatment outcomes as an adjunct therapy.
Ozge Unlu, Nil Yakar, Alpdogan Kantarci
wiley   +1 more source

Burkholderia cepacia complex in septicaemic non-cystic fibrosis cases from two tertiary care hospitals in north India [PDF]

open access: yes, 2010
Arora, Anita   +12 more
core   +2 more sources

Fosmidomycin for the Treatment of Canine Otitis Externa: A Randomised, Double‐Blinded, Controlled ‘Split Body’ Clinical Trial

open access: yesVeterinary Dermatology, EarlyView.
ABSTRACT Background Targeted antimicrobial therapy for canine otitis externa (OE) represents an opportunity for antimicrobial stewardship. Fosmidomycin selectively inhibits the non‐mevalonate pathway for isoprenoid biosynthesis utilised by canine‐adapted, and not human‐adapted, staphylococci.
Lindsey E. Citron   +6 more
wiley   +1 more source

Application and Limitations of 16S rRNA Gene Sequencing for Identifying WHO Priority Pathogenic Gram-Negative Bacilli. [PDF]

open access: yesInfect Drug Resist
de Souza PA   +5 more
europepmc   +1 more source

Bacterial proliferation is comparable in red blood cell concentrates stored in DEHT/PAGGSM and DEHP/SAGM containers

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives The European Union's ban on the use of di(2‐ethylhexyl) phthalate (DEHP) in medical devices will take effect in 2030. DEHP is a plasticizer in polyvinyl chloride blood bags that helps stabilize the red blood cell membrane during hypothermic red blood cell concentrate (RBCC) storage.
Sandra Ramirez‐Arcos   +8 more
wiley   +1 more source

Pathogen‐reduced platelet concentrates in France: Impact on the risk of transfusion‐transmitted infections, 2017–2024

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Pathogen reduction (PR) using amotosalen‐UVA was implemented for 100% of platelet concentrates (PCs) in France in November 2017. No bacterial testing was in place earlier. The impact of PR on the risk of transfusion‐transmitted infections (TTIs) from November 2017 to December 2022 (vs.
Syria Laperche   +11 more
wiley   +1 more source

Characterization of Carbapenem-Resistant Gram-Negative Bacilli Isolates in Multispecialty Private Hospitals in Lagos, Nigeria. [PDF]

open access: yesInfect Dis Rep
Salau M   +8 more
europepmc   +1 more source

Bacterial screening of platelet donations in England, 2014–2023

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Bacterial contamination of blood components is an ongoing problem in transfusion medicine. We analysed the bacterial screening data of platelets from England, 2014–2023, and compared this with data on reported near‐misses and transfusion‐transmitted infections (TTIs). Materials and Methods Anonymized data on bacterial
Vidushi Chugh   +6 more
wiley   +1 more source

Antimicrobial Resistance in the One Health Concept in Lebanon

open access: yesJournal of Infection in Developing Countries, 2018
Ziad Daoud
doaj   +1 more source

Home - About - Disclaimer - Privacy